Influenza Clinical Trial
Official title:
An Active, Epidemiological Surveillance Study on Influenza-related Hospitalizations to Intensive Care Units and Fatalities in Paediatric Hospitals in Bavaria Covering the Influenza Seasons 2010/2011 and 2011/2012
The purpose of the study is to assess the number of severe, laboratory-confirmed influenza in children hospitalized to paediatric intensive care units. Furthermore, the proportion of these children from all children hospitalized to paediatric intensive care units with acute respiratory infections will be established.
Accurate epidemiological data on severe influenza-associated hospitalizations and fatalities
in children are lacking in Germany. The purpose of this study is primarily, to assess the
number of severe, laboratory-confirmed influenza in children hospitalized to paediatric
intensive care units due to suspected acute respiratory infections/ influenza/
influenza-triggered complications and in children developing influenza during paediatric
intensive care unit hospitalization, as well as the number of influenza-associated
fatalities. In addition we aim at assessing clinical features, severity, risk factors,
complications, diagnostic procedures, treatment and outcome of severe, laboratory-confirmed
influenza (and other acute respiratory infections) in these children. Another objective is
to estimate the proportion of laboratory-confirmed influenza cases in all children
hospitalized to paediatric intensive care units with acute respiratory infections and to
evaluate the number and proportion of paediatric intensive care unit hospitalizations due to
other viral acute respiratory infections. Additional aims are to estimate the (minimum)
incidence of severe influenza-associated hospitalizations in Bavarian children and to
estimate the (minimum) incidences of other acute respiratory infections.
Ideally, this study will be conducted between October 2010 and March 2012 in all Bavarian
(Germany) hospitals with paediatric intensive care units or paediatric intensive care beds
(neonatology excluded). To optimize reporting there will be one study physician at each site
responsible for documentation, diagnostic procedures and queries. The local study physician
will receive an initiation visit at the start of each season, and will be contacted by the
study coordination (situated at the University Children's Hospital in Wuerzburg) bi-weekly
by phone. This local study physician summarizes the paediatric intensive care unit
admittance in a log sheet, documents epidemiological, demographical, and clinical data in a
questionnaire for all suspected acute respiratory infections/influenza patients with
parental informed consent (pseudonymous data only), and draws a nasopharyngeal swab or -wash
if indicated as routine procedure. A sample will be sent to the central laboratory
(Institute for Virology and Immunobiology, University of Wuerzburg) for analysis
(influenza-polymerase chain reaction, influenza virus subtyping, other viral acute
respiratory infections (respiratory syncytial virus, parainfluenza 1-4, humane
metapneumovirus, adenoviruses, rhinoviruses, enteroviruses). The central laboratory will
analyse the samples timely and report the results to the respective study site. Additional
influenza-tests may also be performed by the local laboratory, at the discretion of the
hospitals. All tests, locally and performed in Wuerzburg, and their outcome should be
reported in the questionnaire.
;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
| Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
| Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
| Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
| Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
| Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
| Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
| Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
| Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
| Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
| Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
| Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
| Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
| Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
| Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
| Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
| Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
| Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |